Current Opinion in Neurology

Papers
(The TQCC of Current Opinion in Neurology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation85
Management of neuropsychiatric symptoms in dementia54
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis52
Chemotherapy and targeted therapies for meningiomas: what is the evidence?50
The recent surge of functional movement disorders: social distress or greater awareness?47
Update on management of cerebral venous thrombosis43
The role of the gut microbiome in Alzheimer's disease pathophysiology41
Editorial introductions39
Microglia in multiple sclerosis – pathogenesis and imaging36
Historical development and contemporary use of neuromodulation in human spinal cord injury33
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies33
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies29
Hereditary motor neuropathies29
Gene therapies for CMT neuropathies: from the bench to the clinic29
From basic mechanisms to therapeutic perspectives in cluster headache27
Central nervous system adverse events of immune checkpoint inhibitors26
Neurology education in the era of artificial intelligence25
The 2021 WHO classification of central nervous system tumors: what neurologists need to know25
Editorial introductions24
Editorial: Epilepsy advances in 202323
Multiple sclerosis in China: the current state of diagnosis and management23
Connecting tremors – a circuits perspective21
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial21
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection21
Thymectomy in myasthenia gravis20
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment20
Updates in neuro-otology20
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery20
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms20
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes20
The FSHD jigsaw: are we placing the tiles in the right position?20
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management20
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise20
Levodopa infusion therapies for Parkinson disease19
Threat of resurgence or hope for global eradication of poliovirus?19
Update on the clinical and therapeutic aspects of myotonic dystrophy type 118
Clinical impact of molecular profiling in rare brain tumors18
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke18
Red flags in multiple sclerosis17
Gauging and controlling excitability in cortical disorders17
Diet and migraine: what is proven?17
Migraine in women: a review17
Acute stroke care in low and middle-income countries17
Nerve ultrasound in the diagnosis of inflammatory neuropathies17
Update on dermatomyositis16
MRI for the diagnosis of limb girdle muscular dystrophies16
Electrical stimulation of the peripheral and central vestibular system16
Idiopathic intracranial hypertension: expanding our understanding16
fMRI-based spatio-temporal parcellations of the human brain16
Editorial: Advances in neuro-oncology: stepping in the right direction16
Parkinson's disease – genetic cause16
Obesity-related neuropathy: the new epidemic16
Optic neuritis: current challenges in diagnosis and management15
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies15
Novel approaches to treatment of leptomeningeal metastases15
New developments in diagnostics and treatment of adult-onset focal dystonia15
Editorial: The gap between academic advances and therapy development in motor neuron disease15
Neuroinflammation and immunometabolism in neurodegenerative diseases15
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications14
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis14
Recent advances in Alzheimer disease genetics14
Targeting IDH1/IDH2 mutations in gliomas14
Neurosyphilis in 202514
Progress in spinal muscular atrophy research14
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers14
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management13
Visually induced dizziness13
Recent insights in striated muscle laminopathies13
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond13
Diagnosing viral encephalitis and emerging concepts13
Fluid phase biomarkers in multiple sclerosis13
Sex and gender differences in neurological infections13
Current trend in air pollution exposure and stroke13
Abnormal energy metabolism in ALS: a key player?13
The state of art on the use of patient reported outcomes in migraine13
Monitoring multiple sclerosis: digital and fluid phase biomarkers13
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health12
Update on modifiable risk factors for Alzheimer's disease and related dementias12
Update on genetics of amyotrophic lateral sclerosis12
Imaging cortical lesions in multiple sclerosis12
New insights in the immune treatment of Guillain–Barré syndrome12
Advanced neuroimaging techniques in epilepsy12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease12
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders11
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection11
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum11
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy11
Editorial: Making the invisible visible: updates on vestibular neurology11
Current gaps in acute reperfusion therapies11
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review10
Long COVID and especially headache syndromes10
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases10
Immune checkpoint inhibitors induced side effects of the peripheral nervous system10
Editorial: Seizure disorders: 2023 update10
Pharmacotherapy of cerebellar and vestibular disorders10
Peripheral visual field loss and activities of daily living10
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies10
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients10
Muscle ultrasound in myopathies9
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success9
Progress in treatment of gliomas9
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period9
An update on psychogenic nonepileptic seizures9
Editorial introductions9
Motion sickness: current concepts and management9
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury9
Nonneurologic causes of binocular diplopia for the neurologist9
Editorial: Cerebrovascular disease9
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?9
Neuro-infectious disorders – reasons to be cheerful but it is a long and winding road9
Multiple sclerosis: advances and challenges in diagnosis9
Therapeutic thoroughfares for adults living with Pompe disease9
Progression in multiple sclerosis – a long-term problem9
Perception and control of a virtual body in immersive virtual reality for rehabilitation9
Ménière's disease: new guidelines, subtypes, imaging, and more9
Interrogating large multiple sclerosis registries and databases: what information can be gained?9
0.057391881942749